VACCINE COMPOSITIONS OF M2e, HA0 AND BM2 MULTIPLE ANTIGENIC PEPTIDES

Method to enhance an immune response of nucleic acid vaccination

PROCESS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS, RHEUMATOID ARTHRITIS, TREMORS/PARKINSON'S DISEASE, MULTIPLE SCLEROSIS AND NON-VIRAL BASED CANCERS

Human papillomavirus / Ii-Key hybrids and methods of use

Pneumococcal polysaccharide conjugate vaccine

VACCINE

Storage of Influenza Vaccines Without Refrigeration

NEW VACCINE FORMULATIONS

bacterin vaccine

H3 equine influenza A virus

proteins and nucleic acids

Method and System for Optimizing Minigenes and Peptides Encoded Thereby

Peptide sequences and compositions

proteins and nucleic acids

Flu vaccines and methods of use thereof

Inactivated FCV vaccines

Inactivated polio vaccines

Chimeric flavivirus immunogens comprising the Japanese encephalitis virus (JEV) prM signal sequence

Vaccine

Multiple vaccination including serogroup C meningococcus

Immunogenic compositions comprising nanoemulsion and hepatitis B virus immunogen and methods of using the same

METHODS OF VACCINE ADMINISTRATION

IPV-DPT vaccine

RECOMBINANT HERPESVIRUS USEFUL IN VACCINE PRODUCTION

Nucleic acids encoding chimeric flavivirus immunogens comprising the Japanese encephalitis virus (JEV) prM signal sequence

Vaccine for disease and streptococcal disease in fish

Production of vaccines

FUSION MULTIVIRAL CHIMERIC ANTIGEN

Refrigerator-temperature stable influenza vaccine compositions

PCV2 MYCOPLASMA HYOPNEUMONIAE IMMUNOGENIC COMPOSITIONS AND METHODS OF PRODUCING SUCH COMPOSITIONS

VACCINE

Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions

Dual variable domain immunoglobulins and uses thereof

Nanoemulsion influenza vaccine

Inducing cellar immune responses to hepatitis C virus using peptide and nucleic acid compositions

Influenza vaccines including combinations of particulate adjuvants and immunopotentiators

Influenza vaccine

Use of Liposomes in a Carrier Comprising a Continuous Hydrophobic Phase as a Vehicle for Cancer Treatment

Method for vaccination of poultry by bacteriophage lysate bacterin

INFLUENZA NUCLEIC ACIDS, POLYPEPTIDES, AND USES THEREOF

NON-TOXIC MUTANTS OF PATHOGENIC GRAM-NEGATIVE BACTERIA

Method for inducing cross-reactive immune responses to the human immunodeficiency virus (HIV) in a host by administering feline immunodeficiency virus (FIV) capsid (CA) or reverse transcriptase (RT) immunogens

Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus

Vaccine Compositions Comprising Virosomes and a Saponin Adjuvant

Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesis

Virus-like particles as vaccines for paramyxovirus

METHOD OF PRODUCING MENINGOCOCCAL MENINGITIS VACCINE FOR NEISSERIA MENINGITIDIS SEROTYPES A, C, Y, and W-135

Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4

NOVEL PROTEOSOME-LIPOSACCHARIDE VACCINE ADJUVANT

Immunogenic composition

Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences

VACCINE

VIRUS LIKE PARTICLES

Process for stabilizing an adjuvant containing vaccine composition

Adjuvanted influenza vaccines for pediatric use

EMULSIONS WITH FREE AQUEOUS-PHASE SURFACTANT FOR ADJUVANTING SPLIT INFLUENZA VACCINES

Recombinant mononegaviral virus vectors

Vaccines against aids comprising cmv/r-nucleic acid constructs

Adjuvant for vaccines

Mosaic clade M human immunodeficiency virus type 1 (HIV-1) envelope immunogens

COMPOSITION AND METHODS OF MAKING AND USING INFLUENZA PROTEINS

Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine

VACCINE

Manufacturing Method of Combined Vaccine

Expressing hepatitis B virus surface antigen for vaccine preparation

INFLUENZA COMBINATORIAL ANTIGEN VACCINE

Vaccines against multiple subtypes of influenza virus

Inactivated FCV vaccines

HEAT TREATED BACTERINS, AND EMULSION VACCINES PREPARED FROM SUCH HEAT TREATED BACTERINS

Antigens and vaccines against

Antibody production elicited by a DNA vaccine delivered by electroporation

Novel vaccine

Manufacture of Vaccines That Contain Both Hepatitis B Virus Surface Antigen and Surfactant

Immunogenic compositions

Influenza vaccine

Immunogenic composition

COMBINATION VACCINE

Direct vaccination of the bone marrow

Multivalent pneumococcal polysaccharide-protein conjugate composition

Immunogenic polypeptide composed of tumor antigen-derived optimized cryptic peptides, and uses thereof

VACCINE

Purification of HBV antigens for use in vaccines

avirulent adjuvanted live vaccine

IMMUNOPEPTIDES OF HPV E6 AND E7 PROTEINS

Alphavirus Vectors for Respiratory Pathogen Vaccines

Vaccines containing canine parvovirus genetic variants

Multivalent PCV2 immunogenic compositions and methods of producing such compositions

VACCINE FOR NONTYPEABLE HAEMOPHILUS INFLUENZAE INFECTION

COMPOSITION

Dry Formulation for Transcutaneous Immunization

Immunogenic compositions and methods

MVA expressing modified HIV envelope, gag, and pol genes

COMBINATION VACCINE COMPRISING AN ATTENUATED BOVINE VIRAL DIARRHEA VIRUS

Integration of meningococcal conjugate vaccination

Polyvalent conjugate vaccine for cancer

Combination vaccine for poultry

Use of alpha-toxin for treating and preventing staphylococcus infections

CHANGING TH1/TH2 BALANCE IN SPLIT INFLUENZA VACCINES WITH ADJUVANTS

Papillomavirus L2 N-terminal peptides for the induction of broadly cross-neutralizing antibodies

Immunogenic composition

GROUP A STREPTOCOCCAL VACCINES

Novel use

Polyvalent influenza virus-like particle (VLP) compositions

Alphavirus Replicon Particles Matched to Protein Antigens as Immunological Adjuvants

Vaccine

Vaccine Comprising Streptococcus Pneumoniae Capsular Polysaccharide Conjugates

Raccoon poxvirus expressing rabies glycoproteins

Avirulent, immunogenic flavivirus chimeras

Pneumococcal Polysaccharide Conjugate Vaccine

Influenza Vaccination

METHOD OF PRODUCING MENINGOCOCCAL MENINGITIS VACCINE FOR NEISSERIA MENINGITIDIS SEROTYPES A, C, Y, and W-135

Methods and compositions for combinatorial-based production of multivalent recombinant antigens

Vaccines Containing Viruses Involved in Avian Malabsorption Syndrome and Methods of Administration Therefor

Attenuated influenza virus and a live vaccine comprising the same

Vaccine For Periodontal Disease

Immunogenic Composition

Renta: an HIV immunogen and uses thereof

Conjugate Vaccines

Norovirus vaccine formulations

Influenza vaccines

Hexavalent bovine rotavirus reassortant composition designed for use in developing countries

Vaccine Compositions Comprising a Saponin Adjuvant

Mixture of human papillomavirus virus-like particles

INDUCTION OF BROADLY REACTIVE NEUTRALIZING ANTIBODIES BY FOCUSING THE IMMUNE RESPONSE ON V3 EPITOPES OF THE HIV-1 gp120 ENVELOPE

Hla-A2 Tumor Associated Antigen Peptides and Compositions

Lyophilization of virosomes

PROTEOSOME INFLUENZA VACCINE

Method of Vaccination Against Testicular Bvdv Infection

COMPOSITION AND METHOD FOR CONTROLLING INTESTINAL PATHOGENIC ORGANISMS

Saccharide Conjugate Vaccines

Chimeric sindbis-western equine encephalitis virus and uses thereof

Vaccine for veterinary and human medicine prophylaxis and therapy

Combined meningococcal conjugates with common carrier protein

Methods and compositions for live attenuated viruses

Papillomavirus vaccine compositions

Multivalent immunogenic composition containing RSV subunit compostion and influenza virus preparation

Process for the preparation and use of a bivalent vaccine against morphine-heroine addiction

Liquid vaccines for multiple meningococcal serogroups

Vaccine Composition

Use of penetration enhancers and barrier disruption methods to enhance the immune response of an antigen

STABLE POWDER FORMULATIONS OF ALUM-ADSORBED VACCINES

Multivalent avian influenza vaccines and methods

Adjuvant systems and vaccines

Canine combination vaccines

MULTIVALENT PCV2 IMMUNOGENIC COMPOSITIONS AND METHODS OF PRODUCING SUCH COMPOSITIONS

Multi-antigenic alphavirus replicon particles and methods

Vaccine

Immunogenic composition

Infectious Bursal Disease Virus antigenic isolates and vaccines

Vaccination Against Dengue Virus Infection

Immunogenic composition

Soft gel delivery system for treating poultry

Vaccine formulations

NOVEL VACCINE COMPOSITION

IGF-1 AS FELINE VACCINE ADJUVANT, IN PARTICULAR AGAINST FELINE RETROVIRUSES

Use Of An Influenza Virus, An Oil-In-Water Emulsion Adjuvant, To Induce Cd4 T-Cell And/Or Improved B-Memory Cell Response

CANINE VACCINES

Novel Composition

PLANT-PRODUCED COMPOSITIONS FOR TREATING PAPILLOMAVIRUS INFECTION AND RELATED METHODS

Therapy of cancer based on targeting adaptive, innate and/or regulatory component of the immune response

Vaccine Composition Against Hepatitis C Virus

Method of immunization against the 4 serotypes of dengue fever

Use of alpha-toxin for treating and preventing staphylococcus infections

Avian influenza viruses, vaccines, compositions, formulations, and methods

Novel Composition

bacteriophage and uses thereof

Recombinant Herpesvirus Useful in Vaccine Production

Hybrid Shiga-like toxin

Attenuated parainfluenza virus (PIV) vaccines

Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus

Composition comprising iscom particles and live micro-organisms

Immunological combination compositions and methods

Method of immunization against the 4 dengue serotypes

VACCINE COMPOSITION

Use of penetration enhancers and barrier disruption methods to enhance the immune response of antigen and adjuvant

Human papilloma virus treatment

Influenza virus vaccine composition and methods of use

Encapsidation System for Production of Recombinant Virus-Like Particles

Combination Therapy for Immunostimulation

Method of producing meningococcal meningitis vaccine for serotypes A,C,Y, and W-135

METHOD OF PRODUCING MENINGOCOCCAL MENINGITIS VACCINE FOR NEISSERIA MENINGITIDIS SERO TYPES A,C,Y, and W-135

Method of vaccinating subjects receiving immune modulating therapy

Vaccine against HPV16 and HPV18 and at least another HPV type selected from HPV 31, 45 or 52

Method of immunization against the 4 dengue serotypes

Influenza recombinant subunit vaccine

Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates

Vaccine formulations for intradermal delivery comprising adjuvants and antigenic agents

Influenza virus vaccine composition and methods of use

Compositions and methods useful for modulating immunity, enhancing vaccine efficacy, decreasing morbidity associated with chronic FHV-1 infections, and preventing or treating conjunctivitis

Influenza antigens, vaccine compositions, and related methods

Pharmaceutical Compositions for Therapeutic Use

Rescue of mumps virus from CDNA

Rescue of mumps virus from cDNA

Construction of live attenuated vaccine strains that express CFA/I antigens (CfaB and CfaE) and the B subunit of heat-labile enterotoxin (LTB) from enterotoxigenic

Non-live trivalent influenza vaccine for one-dose intradermal delivery

West Nile vaccine

West nile DNA vaccine

Combination neisserial compositions

Multivalent pneumococcal polysaccharide-protein conjugate composition

Vaccine composition comprising virus-like particles of human papillomavirus

Immunomodulating compositions and uses therefor

Equine herpesvirus vaccine

Thermoreversible oil-in-water emulsion

Functional influenza virus like particles (VLPs)

Multivalent pneumococcal polysaccharide-protein conjugate composition

Methods for preventing or ameliorating West Nile encephalitis

Cold-adapted (CA) reassortant influenza virus

Methods for preventing cattle reproductive diseases

Methods for prevention or amelioration of West Nile encephalitis using a West Nile DNA vaccine

Flavivirus detection methods employing recombinant antigens comprising a Japanese encephalitis (JEV) signal sequence

Methods of inducing flavivirus immune responses through the administration of recombinant flaviviruses comprising an engineered japanese encephalitis virus signal sequence

West Nile vaccine

West Nile vaccine

West Nile vaccine

Methods for preventing cattle reproductive diseases

Anthrax vaccine

bacterin vaccine

Influenza vaccine compositions and methods of use thereof

INFLUENZA VACCINE COMPOSITIONS AND METHODS

Vaccine Comprising a Polysaccharide Antigen-Carrier Protein Conjugate and Free Carrier Protein

Severe acute respiratory syndrome DNA compositions and methods of use

Non-toxic mutants of pathogenic gram-negative bacteria

TISSUE TARGETED ANTIGENIC ACTIVATION OF THE IMMUNE RESPONSE TO CANCERS

Probiotic enterococci for improved immunity

Attenuated dengue virus comprising mutations in the NS3 gene

Multivalent dengue virus vaccine

Injectable vaccines against multiple meningococcal serogroups

Use of human TNFα antibodies for treatment of erosive polyarthritis

Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine

Circovirus sequences associated with piglet weight loss disease (PWD)

Compositions and methods for generating an immune response

Non-toxic mutants of pathogenic gram-negative bacteria

Influenza recombinant subunit vaccine

Influenza recombinant subunit vaccine

Production of multivalent virus like particles

Influenza immunogen and vaccine

Nipah virus vaccines

Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus

Stabilizers for veterinary vaccines

Vaccine

Immuno-adjuvant emulsion

Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4

Postweaning multisystemic wasting syndrome and porcine circovirus from pigs

Method and device for transdermal immunization

Methods and compositions to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma

Postweaning multisystemic wasting syndrome and porcine circovirus from pigs

Postweaning multisystemic wasting syndrome and porcine circovirus from pigs

Compositions and vaccines containing antigen(s) of Cryptosporidium parvum and of another pathogen

Composition

Plasmodium falciparum AMA-1 protein and uses thereof

Functional influenza virus-like particles (VLPs)

Hpv-16 and-18 l1 vlp vaccine

Neisserial vaccine compositions comprising a combination of antigens

Vaccines

alpha toxoid vaccine

Multivalent pneumococcal polysaccharide-protein conjugate composition

Induction of mucosal immunity by vaccination via the skin route

bacterin vaccine

Use of DNA vaccine in combination with a conventional vaccine to overcome immunogen interference

Circovirus sequences associated with piglet weight loss disease (PWD)

Influenza nucleic acids, polypeptides, and uses thereof

Vaccine composition

HIV TEV compositions and methods of use

Multivalent avian influenza vaccines

Immunogenic compositions comprising

Stress proteins and uses therefor

Stress proteins and uses therefor

Composition and method for preventing or treating a virus infection

Sphingoid polyalkylamine conjugates for Hepatitis B virus vaccination

Vaccine formulations for intradermal delivery comprising adjuvants and antigenic agents

Inactivated FCV vaccines

Purification of HBV antigens for use in vaccines

Multivalent immunogenic composition containing RSV subunit composition and influenza virus preparation

H3 equine influenza A virus

Development of a preventive vaccine for filovirus infection in primates

Trivalent vaccine with maternal anitbody transfer via the milk

Polyanionic polymer adjuvants for haemophilus influenzae B saccharide vaccines

Compositions with enhanced immunogenicity

proteins and nucleic acids

Influenza immunogen and vaccine

Immunological combination compositions and methods

Refrigerator-temperature stable influenza vaccine compositions

Vaccine

Production of vaccines

Avirulent, immunogenic flavivirus chimeras

Novel vaccine

Vaccine composition

Production of vaccines

Vaccine compositions comprising L2 and/or L3 immunotype lipooligosaccharides from LGTB-

Antigen library immunization

Optimal polyvalent vaccine for cancer

Vaccine composition comprising transferrin binding protein and hsf from gram negative bacteria

Method for preparation of vesicles loaded with biological material and different uses thereof

Porcine circovirus and Helicobacter combination vaccines and methods of use

Influenza virus vaccine composition and methods of use

Vaccine

Postweaning multisystemic wasting syndrome and porcine circovirus from pigs

Transcutaneous immunization without heterologous adjuvant

Subunit vaccine against West Nile viral infection

Vaccine